CN1257706A - 丁基苯酞在制备抗血栓形成及抗血小板聚集药物中的应用 - Google Patents
丁基苯酞在制备抗血栓形成及抗血小板聚集药物中的应用 Download PDFInfo
- Publication number
- CN1257706A CN1257706A CN 98125618 CN98125618A CN1257706A CN 1257706 A CN1257706 A CN 1257706A CN 98125618 CN98125618 CN 98125618 CN 98125618 A CN98125618 A CN 98125618A CN 1257706 A CN1257706 A CN 1257706A
- Authority
- CN
- China
- Prior art keywords
- nbp
- platelet
- thrombosis
- asp
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
剂量(μmol/L) | 胶原诱导(%) | ||||
Asp | dl-NBP | l-NBP | d-NBP | ||
对照 | 78.4±7.1 | ||||
3 | 66.3±8.0* | 60.7±2.8*** | 74.4±13.6 | ||
10 | 58.7±10.2** | 50.2±2.0*** | 72.3±6.0 | ||
30 | 49.2±2.2*** | 35.7±7.0*** | 57.4±4.7*** | ||
100 | 41.7±7.4*** | 34.0±5.2*** | 25.0±10.7*** | 43.8±8.2*** | |
ADP诱导(%) | |||||
Asp | dl-NBP | l-NBP | d-NBP | ||
对照 | 72.4±4.7 | ||||
3 | 64.1±3.9** | 62.4±3.9** | 73.1±5.1 | ||
10 | 59.1±4.1*** | 54.6±2.0*** | 65.5±3.5* | ||
30 | 54.4±7.7*** | 46.5±3.7*** | 65.1±8.8*** | ||
100 | 69.1±6.0 | 48.8±2.7*** | 37.3±2.8*** | 63.6±7.4*** |
剂量(μmol/L) | AA(%) | ||||||
Asp | dl-NBP | l-NBP | d-NBP | ||||
对照 | 78.9±8.6 | ||||||
3 | 70.03±13.22 | 69.3±3.5* | 73.9±5.7 | 66.9±4.2* | |||
10 | 45.52±12.67*** | 48.2±2.6** | 59.2±4.5*** | 47.1±5.2*** | |||
30 | 37.2±13.02*** | 33.4±5.2*** | 33.4±2.7*** | 41.2±7.4*** | |||
100 | 0±0*** | 2.6±4.5*** | 0±0*** | 4.6±4.1*** | |||
凝血酶诱导(%) | |||||||
Asp | dl-NBP | l-NBP | d-NBP | ||||
对照 | 72.4±4.7 | ||||||
3 | 83.7±5.4 | 85.7±4.5 | 86.4±4.3 | ||||
10 | 84.9±7.9 | 82.4±7.5 | 85.9±7.6 | ||||
30 | 76.8±16.4 | 72.7±11.8 | 82.2±9.5 | ||||
100 | 54.2±7.3** | 70.2±7.3 | 70.9±9.9 | 78.6±11.2 |
剂量(μmol/l) | cAMP(pmol/109血小板) | ||||
Dl-NBP | l-NBP | d-NBP | |||
对照 | 8.50±3.14 | ||||
1.0 | 9.89±2.20 | 11.54±3.59 | 9.20±5.71 | ||
10 | 16.52±5.17** | 13.92±5.02* | 8.56±6.67 | ||
100 | 16.34±2.93*** | 19.89±10.44* | 12.70±7.89 | ||
TXB2(μg/109血小板) | |||||
dl-NBP | l-NBP | d-NBP | |||
对照 | 3.88±0.45 | ||||
1.0 | 3.60±0.48 | 3.29±0.33 | 3.68±0.35 | ||
10 | 3.67±0.28 | 3.57±0.45 | 3.41±0.21 | ||
100 | 2.93±0.66 | 2.94±0.41* | 3.29±0.56 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98125618A CN1086942C (zh) | 1998-12-18 | 1998-12-18 | 丁基苯酞在制备抗血栓形成及抗血小板聚集药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98125618A CN1086942C (zh) | 1998-12-18 | 1998-12-18 | 丁基苯酞在制备抗血栓形成及抗血小板聚集药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1257706A true CN1257706A (zh) | 2000-06-28 |
CN1086942C CN1086942C (zh) | 2002-07-03 |
Family
ID=5229237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98125618A Expired - Lifetime CN1086942C (zh) | 1998-12-18 | 1998-12-18 | 丁基苯酞在制备抗血栓形成及抗血小板聚集药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1086942C (zh) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004018444A1 (fr) * | 2002-08-21 | 2004-03-04 | Shijiazhuang Pharma Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Clathrates de phtalide butylique associe a de la cyclodextrine ou a ses derives, procede de preparation desdites compositions et leur utilisation |
WO2005053658A1 (fr) * | 2003-12-05 | 2005-06-16 | Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology(Shijiazhuang) Co., Ltd. | Capsule molle de butylphthalide et procede de preparation correspondant |
WO2005102314A1 (fr) * | 2004-04-23 | 2005-11-03 | Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology(Shijiazhuang) Co., Ltd. | Utilisation d'homologues de butylphthalide dans la preparation d'un medicament destine au traitement et a la prevention de l'ischemie cerebrale |
WO2006021160A1 (fr) | 2004-08-27 | 2006-03-02 | Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Système de relargage de médicament auto-émulsifiant à base de butylbenzènephtaléine, méthode de préparation et applications d’un tel système |
WO2007068212A1 (fr) | 2005-12-16 | 2007-06-21 | Shijiazhuang Pharma Group Nbp Pharmaceutical Co., Ltd. | Emulsion intraveineuse de butylbenzene phtaleine et son application |
CN1331469C (zh) * | 2004-04-05 | 2007-08-15 | 王弢 | 一种苯酞类二聚体的用途 |
EP1709962A4 (en) * | 2004-01-20 | 2010-02-10 | Shijiazhuang Pharma Group | USE OF L-BUTYLPHTALIDE IN THE MANUFACTURE OF MEDICAMENTS FOR THE PREVENTION AND TREATMENT OF BRAIN ISCHEMIA-INDUCED DISEASE |
EP1679070A4 (en) * | 2003-10-10 | 2010-02-17 | Shijiazhuang Pharma Group | USE OF L-BUTYLPHTALIDE IN THE MANUFACTURE OF MEDICAMENTS FOR THE PREVENTION AND TREATMENT OF CEREBRAL INFARCTION |
CN101337891B (zh) * | 2008-05-19 | 2011-07-20 | 中国药科大学 | 一氧化氮供体型丁基苯酞衍生物、其制备方法及医药用途 |
CN101289438B (zh) * | 2007-04-16 | 2012-04-18 | 山东绿叶天然药物研究开发有限公司 | 3-(3'-羟基)-丁基苯酞酯及其制法和用途 |
CN101627992B (zh) * | 2004-01-20 | 2012-09-12 | 石药集团中奇制药技术(石家庄)有限公司 | 左旋丁苯酞在制备治疗脑卒中药物中的应用 |
WO2013053287A1 (zh) * | 2011-10-13 | 2013-04-18 | 石家庄以岭药业股份有限公司 | 一种丁苯酞的衍生物及其制法和用途 |
WO2014040524A1 (zh) | 2012-09-14 | 2014-03-20 | 中山大学 | 3-正丁基异吲哚啉酮在制备预防和治疗脑梗塞的药物中的应用 |
-
1998
- 1998-12-18 CN CN98125618A patent/CN1086942C/zh not_active Expired - Lifetime
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002327307B8 (en) * | 2002-08-21 | 2009-02-26 | Shijiazhuang Pharma Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Clathrates of butylphtualide with cyclodextrin or its derivatives, a process for their preparations and the use there of |
WO2004018444A1 (fr) * | 2002-08-21 | 2004-03-04 | Shijiazhuang Pharma Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Clathrates de phtalide butylique associe a de la cyclodextrine ou a ses derives, procede de preparation desdites compositions et leur utilisation |
US7678776B2 (en) | 2002-08-21 | 2010-03-16 | Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Inclusion complexes of butylphthalide with cyclodextrin or its derivatives, a process for their preparation and the use thereof |
CN102008464B (zh) * | 2003-10-10 | 2012-08-29 | 石药集团中奇制药技术(石家庄)有限公司 | 左旋丁基苯酞在制备治疗脑梗塞的药物中的应用 |
EP2974722A1 (en) * | 2003-10-10 | 2016-01-20 | Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Use of l-butylphthalide in the manufacture of medicaments for prevention and treatment of cerebral infarct |
EP2689776A1 (en) * | 2003-10-10 | 2014-01-29 | Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Use of l-butylphthalide in the manufacture of medicaments for prevention and treatment of cerebral infarct |
US8598225B2 (en) | 2003-10-10 | 2013-12-03 | Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Use of L-butylphthalide in the manufacture of medicaments for treatment of cerebral infarct |
EP1679070A4 (en) * | 2003-10-10 | 2010-02-17 | Shijiazhuang Pharma Group | USE OF L-BUTYLPHTALIDE IN THE MANUFACTURE OF MEDICAMENTS FOR THE PREVENTION AND TREATMENT OF CEREBRAL INFARCTION |
NO338520B1 (no) * | 2003-12-05 | 2016-08-29 | Cspc Zhongqi Pharmaceutical Tech Shijiazhuang Co Ltd | Mykkapsel av butylftalid |
WO2005053658A1 (fr) * | 2003-12-05 | 2005-06-16 | Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology(Shijiazhuang) Co., Ltd. | Capsule molle de butylphthalide et procede de preparation correspondant |
CN101627992B (zh) * | 2004-01-20 | 2012-09-12 | 石药集团中奇制药技术(石家庄)有限公司 | 左旋丁苯酞在制备治疗脑卒中药物中的应用 |
EP1709962A4 (en) * | 2004-01-20 | 2010-02-10 | Shijiazhuang Pharma Group | USE OF L-BUTYLPHTALIDE IN THE MANUFACTURE OF MEDICAMENTS FOR THE PREVENTION AND TREATMENT OF BRAIN ISCHEMIA-INDUCED DISEASE |
EP2682117A1 (en) * | 2004-01-20 | 2014-01-08 | Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | The use of L-butylphthalide in the manufacturing of medicines for the prevention and treatment of cerebral ischemia disease |
US9795585B2 (en) | 2004-01-20 | 2017-10-24 | CSPC Zhongqi Pharmaceutical Technology (Shijizhuang) Co. Ltd. | Methods of using L-butylphthalide for the prevention and treatment of cerebral ischemia disease |
CN1331469C (zh) * | 2004-04-05 | 2007-08-15 | 王弢 | 一种苯酞类二聚体的用途 |
WO2005102314A1 (fr) * | 2004-04-23 | 2005-11-03 | Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology(Shijiazhuang) Co., Ltd. | Utilisation d'homologues de butylphthalide dans la preparation d'un medicament destine au traitement et a la prevention de l'ischemie cerebrale |
CN100435792C (zh) * | 2004-04-23 | 2008-11-26 | 石药集团中奇制药技术(石家庄)有限公司 | 丁基苯酞类同系物在制备治疗抗血小板聚集和抗血栓药物中的应用 |
KR100887034B1 (ko) * | 2004-08-27 | 2009-03-04 | 스자좡 파마 그룹 중치 파마슈티컬 테크놀로지 (스자좡) 컴퍼니 리미티드 | 부틸프탈라이드 자가 에멀젼화 약물 전달 시스템, 그 제조방법 및 응용 |
WO2006021160A1 (fr) | 2004-08-27 | 2006-03-02 | Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Système de relargage de médicament auto-émulsifiant à base de butylbenzènephtaléine, méthode de préparation et applications d’un tel système |
US8728518B2 (en) | 2004-08-27 | 2014-05-20 | Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd | Butylphthalide self-emulsifying drug delivery system, its preparation and method and application |
US10463614B2 (en) | 2005-12-16 | 2019-11-05 | Shijiazhuang Pharma Group Nbp Pharmaceutical Co. | Butylphthalide intravenous emulsion and application thereof |
WO2007068212A1 (fr) | 2005-12-16 | 2007-06-21 | Shijiazhuang Pharma Group Nbp Pharmaceutical Co., Ltd. | Emulsion intraveineuse de butylbenzene phtaleine et son application |
CN101289438B (zh) * | 2007-04-16 | 2012-04-18 | 山东绿叶天然药物研究开发有限公司 | 3-(3'-羟基)-丁基苯酞酯及其制法和用途 |
CN101337891B (zh) * | 2008-05-19 | 2011-07-20 | 中国药科大学 | 一氧化氮供体型丁基苯酞衍生物、其制备方法及医药用途 |
US9278087B2 (en) | 2011-10-13 | 2016-03-08 | Shijiazhuang Yiling Pharmaceutical Co., Ltd. | Derivative of butylphthalide and preparation method and use thereof |
RU2593260C2 (ru) * | 2011-10-13 | 2016-08-10 | Шицзячжуан Илин Фармасьютикал Ко., Лтд. | Производное бутилфталида, способ его получения и применение |
WO2013053287A1 (zh) * | 2011-10-13 | 2013-04-18 | 石家庄以岭药业股份有限公司 | 一种丁苯酞的衍生物及其制法和用途 |
WO2014040524A1 (zh) | 2012-09-14 | 2014-03-20 | 中山大学 | 3-正丁基异吲哚啉酮在制备预防和治疗脑梗塞的药物中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1086942C (zh) | 2002-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1086942C (zh) | 丁基苯酞在制备抗血栓形成及抗血小板聚集药物中的应用 | |
US20030109543A1 (en) | Novel combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination | |
US4444778A (en) | Method and composition for treating atherosclerosis | |
Wang et al. | Ent-16β, 17-dihydroxy-kauran-19-oic acid, a kaurane diterpene acid from Siegesbeckia pubescens, presents antiplatelet and antithrombotic effects in rats | |
CN101541782A (zh) | 作为凝血酶受体拮抗剂的二环和三环衍生物 | |
Shapiro | Warfarin Sodium Derivative:(Coumadin® Sodium) An Intravenous Hypoprothrombinemia-Inducing Agent | |
AU703863B2 (en) | Use of aromatic halides for treating mammalian cell proliferation | |
WO2021070200A2 (en) | Stable compositions of (7as,2's)-2-oxoclopidogrel and its pharmaceutical salts | |
WO2023036093A1 (zh) | 酮酰胺衍生物及其应用 | |
Song et al. | Effects of scorpion venom bioactive polypolypeptides on platelet aggregation and thrombosis and plasma 6-keto-PG F1α and TXB2 in rabbits and rats | |
CN103768047A (zh) | 野黄芩素在制备用于预防和/或治疗血栓性疾病的药物中的用途 | |
CN110833545B (zh) | 脱水亚硝基尼索地平在制备防治脓毒症的药物中的应用 | |
CN102241735A (zh) | 用于预防及治疗急性冠脉综合症及抗凝抗血栓治疗的多肽及其应用 | |
Liu et al. | Phillygenin, a lignan compound, inhibits hypertension by reducing PLCβ3-dependent Ca2+ oscillation | |
CN107108608A (zh) | 1,2,4‑三唑并[4,3‑a]吡啶化合物及其作为mGluR2受体的正向别构调节剂的用途 | |
CN106974899A (zh) | 抗凝血化合物及其用途 | |
AU2016225813B2 (en) | Novel Uses for Traditional Chinese Medicine | |
CN101070338A (zh) | 丹参酮ⅱa磺酸钾用于制备预防和治疗心肌缺血缺氧、脑缺血缺氧的药物 | |
CN1314402C (zh) | 含有蒺藜果总皂苷的药物组合物及其制备方法 | |
McNaughton et al. | Inhibition of human α1E subunit‐mediated Ca2+ channels by the antipsychotic agent chlorpromazine | |
CN102085204A (zh) | 一种抗血小板聚集的药物组合物 | |
JPH05306252A (ja) | 新規マクロカルパール類及びその製造法 | |
CN102764250B (zh) | 一种由牛磺酸和银杏内酯a组成的组合物及其用途 | |
CN110123916A (zh) | 一种治疗痛风性关节炎的外用植物精华、其制备方法及应用 | |
JPS63501360A (ja) | 血栓性および血栓塞栓性疾患の治療のためのプロスタサイクリン、その類縁体またはプロスタグランジンおよびトロンボキサン類縁体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: INST. OF PHARMACOLOGY, CHINESE ACADEMY OF MEDICIN Free format text: FORMER OWNER: INST. OF PHARMACOLOGY, CHINESE ACADEMY OF MEDICINE Effective date: 20040514 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20040514 Patentee after: Institute of Materia Medica of Chinese Academy of Medical Sciences Patentee after: Zhongqi Pharmaceutical Technology (Shijizhuang) Co., Ltd. Patentee before: Institute of Materia Medica of Chinese Academy of Medical Sciences |
|
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 100050 Beijing street, xiannongtan Co-patentee after: Zhongqi Pharm Tech (Shijiazhuang) Co., Ltd., Shiyao Group Patentee after: Institute of Materia Medica of Chinese Academy of Medical Sciences Address before: 100050 Beijing street, xiannongtan Co-patentee before: Zhongqi Pharmaceutical Technology (Shijizhuang) Co., Ltd. Patentee before: Institute of Materia Medica of Chinese Academy of Medical Sciences |
|
CX01 | Expiry of patent term |
Granted publication date: 20020703 |
|
CX01 | Expiry of patent term |